Driving Factors of Decision Making for Prophylactic Salpingectomy Versus Tubal Ligation at the Time of Cesarean Section

Sponsor
Bartin State Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03830502
Collaborator
(none)
58
3
11.7
19.3
1.7

Study Details

Study Description

Brief Summary

Prophylactic (Opportunistic) salpingectomy is a cost-effective strategy recommended for reducing the risk of ovarian cancer at the time of gynecologic surgery in women who have completed childbearing. Similar evidence for cesarean section is growing. However, salpingectomy refers to the surgical removal of a female reproductive organ. Some women may have hesitations about salpingectomy with regard to religious concerns, reduced self-image, tubal reanastomosis or lack of knowledge.

The investigators aimed to explore the underlying factors that motivate women for either decisions.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Surgical sterilization

Detailed Description

Prophylactic and opportunistic bilateral salpingectomy is an increasing trend among surgeons and also proven as an effective risk-reducing method for ovarian cancer.

The investigators have experienced denials among women who were seeking tubal ligation as a sterilization procedure during cesarean section after a comprehensive counseling for prophylactic salpingectomy. Therefore, the investigators aimed to assess the driving factors of decision making for prophylactic salpingectomy or tubal ligation. It is planned to preoperatively have a non-validated questionnaire for the women after a detailed briefing.

Study Design

Study Type:
Observational
Actual Enrollment :
58 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Driving Factors of Decision Making for Prophylactic Salpingectomy Versus Tubal Ligation at the Time of Cesarean Section
Actual Study Start Date :
Feb 10, 2019
Actual Primary Completion Date :
Dec 10, 2019
Actual Study Completion Date :
Feb 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Salpingectomy

Women who gave consent for opportunistic prophylactic bilateral salpingectomy during cesarean section as a Surgical sterilization procedure

Procedure: Surgical sterilization
Surgical sterilization either standard salpingectomy or tubal ligation with Pomeroy technique

Tubal ligation

Women who refused salpingectomy and gave consent for tubal ligation during cesarean section as a Surgical sterilization procedure

Procedure: Surgical sterilization
Surgical sterilization either standard salpingectomy or tubal ligation with Pomeroy technique

Outcome Measures

Primary Outcome Measures

  1. Motivators for sterilization type [Evaluation at preoperative 32th gestational weeks]

    A non-validated data collection tool with open-ended questions assessing the factors behind the decision of salpingectomy or tubal ligation. Data collection tool questions why patients choosed or refused salpingectomy in detail. It is not a scale and does not have a range.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Women seeking for surgical sterilization during their cesarean section

  • Elective and Category 2 or more planned cesarean sections

Exclusion Criteria:
  • Clinical conditions that lead to planned cesarean hysterectomy such as placenta percreata

  • History of ovarian cancer, previous chemotherapy or radiation

  • Women who previously underwent sterilization

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bartin State Hospital Bartin Turkey
2 Istanbul Sisli Hamidiye Etfal Training And Research Hospital, Health Sciences University Istanbul Turkey
3 Medicalpark Gaziosmanpasa Hospital, Istinye University Istanbul Turkey

Sponsors and Collaborators

  • Bartin State Hospital

Investigators

  • Principal Investigator: Murat Yassa, M.D., Specialist

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Murat Yassa, Principal Investigator, Bartin State Hospital
ClinicalTrials.gov Identifier:
NCT03830502
Other Study ID Numbers:
  • EtfalSalp
First Posted:
Feb 5, 2019
Last Update Posted:
Apr 30, 2020
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Murat Yassa, Principal Investigator, Bartin State Hospital

Study Results

No Results Posted as of Apr 30, 2020